
|Articles|August 20, 2012
Considerations for the Development and Manufacturing of Biosimilars [Presentation]
Advertisement
This content is provided by Amgen.
Divided into 3 sections, this presentation provides insight into the complexities of developing and manufacturing biologics and discusses considerations for the development of biosimilars.
Please click the image below to view the presentation.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug
2
Unvaccinated COVID-19 Infection Tied to Higher Myocarditis Risk
3
ACO-SWITCH to Evaluate Tafamidis-to-Acoramidis Switch in ATTR-CM
4
As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning
5



